Does Sunscreen Absorb Into Your Bloodstream? FDA Data

“The FDA found sunscreen chemicals in people’s blood. Stop putting it on your skin.” Versions of that warning resurface every summer, anchored to the same pair of trials and missing what those trials measured. The measurements are real. The panic layered on top of them outruns the data.

What the FDA Sunscreen Absorption Study Actually Measured

The question started inside the FDA itself. The sunscreen rules on the books predate modern evidence on how much of a topical product passes through skin, so agency researchers ran the experiment. Maximum usage trials are the standard pharmacology tool for measuring how much of a topical drug reaches circulation, and the first one, published in JAMA in 2019, followed 24 volunteers wearing four products for four days, with blood samples tracked over a week. The 2020 follow-up expanded to 48 volunteers, six filters, and three weeks of sampling.

The design was a deliberate stress test. Volunteers applied sunscreen at 2 milligrams per square centimeter, the density used to certify an SPF label, across 75 percent of their body surface, reapplying four times a day under clinical supervision.

The result that detonated the headlines: geometric mean maximum plasma concentrations of all six filters, avobenzone, oxybenzone, octocrylene, homosalate, octisalate, and octinoxate, exceeded the FDA’s 0.5 ng/mL screening threshold, and in the 2020 trial the line was crossed on day 1 after a single application. Oxybenzone produced the highest levels of sunscreen ingredients in blood plasma measured in either trial, a geometric mean peak of 258.1 ng/mL for one lotion. Avobenzone bloodstream levels, the trials’ primary endpoint, peaked between 1.8 and 7.1 ng/mL.

Both JAMA papers end with the same sentence: “These findings do not indicate that individuals should refrain from the use of sunscreen.”

Where the 0.5 ng/mL Threshold Comes From

Under the FDA’s framework, crossing the line opens a testing obligation. The 0.5 ng/mL figure descends from the agency’s threshold-of-toxicological-concern logic, laid out in its 2019 proposed rule and maximal usage trial guidance: a plasma concentration low enough that even a molecule with zero safety data would carry a theoretical cancer risk under one in 100,000. Filters that stay beneath it can have some nonclinical toxicology studies waived. Crossing it moves systemic carcinogenicity, developmental, and reproductive studies back onto the table. That is exactly what the FDA then requested.

Detection answers a single question: whether the molecule got in. It says nothing about what the amount does once it arrives. Caffeine reaches the bloodstream by design, and the useful conversation is always dose and effect. The same logic applies here, which keeps this a separate question from the one around sunscreen pills, where the unresolved issue is that oral products have never demonstrated photoprotection at all. Absorbing through skin and working from inside the body are different claims that require different evidence.

Four Applications, 75 Percent of a Body, Four Days

The trial conditions set the ceiling that headlines quoted as an average. The 2 mg/cm² test dose is two to four times what people actually use; field studies reviewed in the Journal of the American Academy of Dermatology put typical application at 0.5 to 1 mg/cm². Layer four supervised reapplications a day over three-quarters of the body on top, and the measured concentrations sit closer to a worst case than to a beach afternoon. Oxybenzone’s peak was roughly 516 times the screening threshold, and it was produced in a clinic, on 48 volunteers, at a dose nobody wears to the shore.

That is the point of a stress test: find the boundary, then study it. The same trials showed several filters staying above the threshold for days after the last application, evidence of accumulation that justified continued study. Both facts stand. The design likely overstates everyday exposure while confirming that absorption is real enough to demand answers.

What Chemical Sunscreen Safety Data Is Still Missing

Seven years after the first trial, the requested studies remain largely undone. The FDA’s September 2026 Q&A lists twelve chemical filters, including oxybenzone, avobenzone, octocrylene, homosalate, octisalate, and octinoxate, as lacking sufficient data for a safety determination. The 2021 proposed order notice states this does not represent a conclusion that the ingredients are unsafe. The file is incomplete. The products stay on shelves while industry fills it.

The record also shows what happens when detection data arrives complete. In June 2026 the FDA added bemotrizinol to the sunscreen monograph, the first new active in over 20 years, while acknowledging that it shows “low levels of absorption through the skin into the body.” Systemic absorption, fully characterized, can coexist with a clean safety verdict. That distinction is what the headlines flattened.

The question underneath the panic, whether chemical sunscreen is bad for you, has a narrower answer than the internet suggests. FDA’s consumer guidance says some actives are absorbed and enter the body, that more data is needed to determine whether any safety risks are associated, and that Americans should use sunscreen alongside other sun protection. Ultraviolet radiation is an established human carcinogen, and it is the hazard sunscreen demonstrably reduces.

Should You Switch to Mineral Filters?

If the open questions bother you, the choice takes about fifteen seconds to act on. Zinc oxide and titanium dioxide are the two filters the FDA has proposed as GRASE with sufficient data, and they do not penetrate intact skin. The chemical vs mineral comparison lays out the tradeoffs in feel, photostability, and marine impact, and the guide to reading a sunscreen ingredient label shows how to spot mineral-only formulas on the back of the bottle.

The corrected version of the belief: chemical sunscreen ingredients do reach the bloodstream; the FDA measured that deliberately because its own screening threshold demanded study. Seven years of follow-up have not produced evidence that the levels detected cause harm, and the agency’s advice has not moved. Keep using sunscreen while the data comes in.